Brief: Aerovate Therapeutics Shares Open At Double The IPO Price In Debut On Nasdaq
30/06/2021 15:52
June 30 (Reuters) -
* AEROVATE THERAPEUTICS SHARES OPEN AT $28.00 IN NASDAQ
DEBUT
VERSUS IPO PRICE OF $14.00/SHARE
Further company coverage: AVTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million